Investigational Site Number :3920009

Yokohama, Kanagawa 236-0004

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Neurodermatitis

Studies at this site

• A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD — Running, not enrolling
• Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME) — Completed